Variant report
Variant | esv3394728 |
---|---|
Chromosome Location | chr15:50707960-50712658 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:59)
- CpG islands (count:0)
- Chromatin interactive region (count:11)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr15:50710290-50710612 | K562 | blood: | n/a | n/a |
2 | ATF3 | chr15:50710267-50710672 | K562 | blood: | n/a | n/a |
3 | BHLHE40 | chr15:50710422-50710622 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr15:50710304-50710678 | Hela-S3 | cervix: | n/a | n/a |
5 | CEBPB | chr15:50710297-50710639 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr15:50710286-50710663 | HepG2 | liver: | n/a | n/a |
7 | CEBPB | chr15:50710441-50710528 | IMR90 | lung: | n/a | n/a |
8 | CEBPB | chr15:50710268-50710678 | K562 | blood: | n/a | n/a |
9 | CEBPB | chr15:50710389-50710549 | A549 | lung: | n/a | n/a |
10 | CTCF | chr15:50709685-50709733 | Fibrobl | skin: | n/a | n/a |
11 | CTCF | chr15:50709737-50709750 | Fibrobl | skin: | n/a | n/a |
12 | CUX1 | chr15:50710453-50710654 | K562 | blood: | n/a | n/a |
13 | E2F6 | chr15:50708312-50708738 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | EP300 | chr15:50710401-50710630 | Hela-S3 | cervix: | n/a | n/a |
15 | EP300 | chr15:50710334-50710643 | K562 | blood: | n/a | n/a |
16 | FOXA1 | chr15:50708058-50708520 | HepG2 | liver: | n/a | n/a |
17 | FOXA2 | chr15:50708071-50708462 | HepG2 | liver: | n/a | n/a |
18 | HCFC1 | chr15:50708124-50708461 | K562 | blood: | n/a | n/a |
19 | JUN | chr15:50710289-50710518 | K562 | blood: | n/a | n/a |
20 | JUN | chr15:50709861-50711380 | K562 | blood: | n/a | chr15:50709990-50710001 chr15:50710974-50710983 chr15:50710084-50710093 |
21 | JUND | chr15:50710236-50710822 | K562 | blood: | n/a | n/a |
22 | JUND | chr15:50710343-50710559 | HepG2 | liver: | n/a | n/a |
23 | MAX | chr15:50710354-50710652 | K562 | blood: | n/a | n/a |
24 | MAZ | chr15:50710394-50710658 | K562 | blood: | n/a | n/a |
25 | MXI1 | chr15:50708222-50708534 | HepG2 | liver: | n/a | n/a |
26 | MYC | chr15:50708286-50708422 | K562 | blood: | n/a | n/a |
27 | MYC | chr15:50710440-50710737 | K562 | blood: | n/a | n/a |
28 | NFYA | chr15:50708368-50708565 | Hela-S3 | cervix: | n/a | n/a |
29 | NFYA | chr15:50708313-50708532 | K562 | blood: | n/a | n/a |
30 | NFYB | chr15:50708328-50708571 | GM12878 | blood: | n/a | n/a |
31 | NFYB | chr15:50708252-50708575 | K562 | blood: | n/a | n/a |
32 | POLR2A | chr15:50710391-50710395 | MCF-7 | breast: | n/a | n/a |
33 | POLR2A | chr15:50708726-50709090 | SK-N-MC | brain: | n/a | n/a |
34 | POLR2A | chr15:50710369-50710370 | Gliobla | brain: | n/a | n/a |
35 | POLR2A | chr15:50710398-50710404 | A549 | lung: | n/a | n/a |
36 | POLR2A | chr15:50710212-50710386 | MCF-7 | breast: | n/a | n/a |
37 | POLR2A | chr15:50710342-50710391 | A549 | lung: | n/a | n/a |
38 | POLR2A | chr15:50710329-50710330 | A549 | lung: | n/a | n/a |
39 | POLR2A | chr15:50709713-50709743 | MCF-7 | breast: | n/a | n/a |
40 | POLR2A | chr15:50710337-50710382 | MCF-7 | breast: | n/a | n/a |
41 | POLR2A | chr15:50710380-50710488 | Gliobla | brain: | n/a | n/a |
42 | RCOR1 | chr15:50710462-50710705 | HepG2 | liver: | n/a | n/a |
43 | RCOR1 | chr15:50710281-50710747 | K562 | blood: | n/a | n/a |
44 | REST | chr15:50710290-50710399 | K562 | blood: | n/a | chr15:50710355-50710375 chr15:50710361-50710370 |
45 | REST | chr15:50710279-50710435 | PFSK-1 | brain: | n/a | chr15:50710355-50710375 chr15:50710361-50710370 |
46 | REST | chr15:50709630-50709881 | K562 | blood: | n/a | chr15:50709778-50709798 chr15:50709784-50709798 chr15:50709786-50709796 |
47 | REST | chr15:50710186-50710503 | PFSK-1 | brain: | n/a | chr15:50710355-50710375 chr15:50710361-50710370 |
48 | REST | chr15:50710108-50710529 | U87 | brain: | n/a | chr15:50710355-50710375 chr15:50710361-50710370 |
49 | REST | chr15:50710134-50710530 | PFSK-1 | brain: | n/a | chr15:50710355-50710375 chr15:50710361-50710370 |
50 | REST | chr15:50710218-50710529 | U87 | brain: | n/a | chr15:50710355-50710375 chr15:50710361-50710370 |
No data |
(count:11 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr15:50664439..50666411-chr15:50707371..50708947,2 | MCF-7 | breast: | |
2 | chr15:50694450..50696893-chr15:50706359..50708089,2 | MCF-7 | breast: | |
3 | chr15:50708008..50710439-chr15:50710908..50713788,3 | MCF-7 | breast: | |
4 | chr15:50702280..50703814-chr15:50705752..50708045,2 | K562 | blood: | |
5 | chr15:50647220..50649637-chr15:50708002..50709799,2 | K562 | blood: | |
6 | chr15:50646196..50649637-chr15:50705519..50710625,4 | K562 | blood: | |
7 | chr15:50693897..50696676-chr15:50706925..50708431,2 | MCF-7 | breast: | |
8 | chr15:50647163..50649970-chr15:50707470..50713022,5 | MCF-7 | breast: | |
9 | chr15:50696757..50701800-chr15:50711495..50716438,5 | K562 | blood: | |
10 | chr15:50644593..50647982-chr15:50708471..50714039,7 | MCF-7 | breast: | |
11 | chr15:50712380..50714768-chr15:50789507..50791340,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
AHCYP7 | TF binding region |
USP8 | TF binding region |
ENSG00000259465 | chromatin interactions |
ENSG00000244879 | chromatin interactions |
ENSG00000259298 | chromatin interactions |
ENSG00000138592 | chromatin interactions |
ENSG00000104064 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7181529 | chr15:50707962-50707963 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs72263779 | chr15:50708074-50708075 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs55721855 | chr15:50708089-50708090 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs549941366 | chr15:50708100-50708101 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs191816525 | chr15:50708107-50708108 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs575758596 | chr15:50708116-50708117 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs550619083 | chr15:50708168-50708169 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs184151731 | chr15:50708169-50708170 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs564634478 | chr15:50708180-50708181 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs12898201 | chr15:50708193-50708194 | Weak transcription Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs528802497 | chr15:50708219-50708220 | Weak transcription Flanking Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs540898561 | chr15:50708259-50708260 | Weak transcription Flanking Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs61021707 | chr15:50708266-50708267 | Weak transcription Flanking Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs145918653 | chr15:50708315-50708316 | Weak transcription Flanking Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs71940259 | chr15:50708316-50708317 | Weak transcription Flanking Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs56286419 | chr15:50708349-50708350 | Weak transcription Flanking Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs561562214 | chr15:50708358-50708359 | Weak transcription Flanking Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs139494674 | chr15:50708395-50708396 | Weak transcription Flanking Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs28410726 | chr15:50708396-50708397 | Weak transcription Flanking Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs186586283 | chr15:50708397-50708398 | Weak transcription Flanking Active TSS Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs555013831 | chr15:50708431-50708432 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs112902133 | chr15:50708433-50708434 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs539469279 | chr15:50708465-50708466 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs537596955 | chr15:50708479-50708480 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs551178772 | chr15:50708504-50708505 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs566304723 | chr15:50708507-50708508 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs189861177 | chr15:50708523-50708524 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs533873223 | chr15:50708560-50708561 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs139584264 | chr15:50708567-50708568 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs369700360 | chr15:50708570-50708571 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs5812514 | chr15:50708571-50708572 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs398043280 | chr15:50708590-50708591 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs117842600 | chr15:50708623-50708624 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
34 | rs182504720 | chr15:50708687-50708688 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs187185708 | chr15:50708713-50708714 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs535157299 | chr15:50708718-50708719 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
37 | rs557349115 | chr15:50708719-50708720 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs201704145 | chr15:50708735-50708736 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs577652415 | chr15:50708897-50708898 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs575821717 | chr15:50708938-50708939 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs555360825 | chr15:50708971-50708972 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs539911175 | chr15:50708974-50708975 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs558410912 | chr15:50709015-50709016 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs573368885 | chr15:50709025-50709026 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs540610189 | chr15:50709029-50709030 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs74012401 | chr15:50709037-50709038 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs115089418 | chr15:50709055-50709056 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs571973136 | chr15:50709060-50709061 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs55931323 | chr15:50709061-50709062 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs397823935 | chr15:50709071-50709072 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21785460 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 22032731 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Cancer | 21129771 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 21364760 | CNVD |
Amyotrophic lateral sclerosis | 20685689 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:50698200-50715800 | Weak transcription | Primary T cells from cord blood | blood |
2 | chr15:50704400-50710400 | Weak transcription | K562 | blood |
3 | chr15:50708000-50708200 | Active TSS | Pancreatic Islets | Pancreatic Islet |
4 | chr15:50708000-50708400 | Enhancers | Hela-S3 | cervix |
5 | chr15:50708000-50708800 | Enhancers | HepG2 | liver |
6 | chr15:50708200-50708400 | Flanking Active TSS | Pancreatic Islets | Pancreatic Islet |
7 | chr15:50708800-50710600 | Weak transcription | HepG2 | liver |
8 | chr15:50709400-50709800 | Weak transcription | Esophagus | oesophagus |
9 | chr15:50709400-50709800 | Enhancers | Spleen | Spleen |
10 | chr15:50709600-50709800 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
11 | chr15:50709600-50709800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
12 | chr15:50709800-50710000 | Enhancers | Esophagus | oesophagus |
13 | chr15:50709800-50715800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
14 | chr15:50710000-50715800 | Weak transcription | Esophagus | oesophagus |
15 | chr15:50710400-50711000 | Enhancers | K562 | blood |
16 | chr15:50710400-50716000 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
17 | chr15:50710600-50711200 | Enhancers | HepG2 | liver |
18 | chr15:50710800-50711000 | Enhancers | Pancreas | Pancrea |
19 | chr15:50711000-50715600 | Weak transcription | Pancreas | Pancrea |
20 | chr15:50711000-50715600 | Weak transcription | K562 | blood |
21 | chr15:50711200-50714400 | Weak transcription | HepG2 | liver |